Recombinant Human ALDH1L1 Protein, His (Fc)-Avi-tagged

• Cat.No.: ALDH1L1-313H
• Product Overview: Recombinant Human ALDH1L1 with His (Fc)-Avi tag was expressed and purified

Specification

• Source: HEK293
• Species: Human
• Tag: His (Fc)-Avi
• Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method
• Purity: ≥85% by SDS-PAGE
• Stability: Stable for at least 6 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles.
• Storage: For long term storage, aliquot and store at -20 to -80 centigrade. Avoid repeated freezing and thawing cycles.
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: ALDH1L1 aldehyde dehydrogenase 1 family member L1 [ Homo sapiens (human) ]
• Official Symbol: ALDH1L1
• Synonyms: FDH; FTHFD; 10-fTHF; 10-FTHFDH
• Gene ID: 10840
• mRNA Refseq: NM_012190.4
• Protein Refseq: NP_036322.2
• MIM: 600249
• UniProt ID: O75891

Reviews

08/17/2022

One notable advantage of using the ALDH1L1 protein is the outstanding technical support provided by its manufacturer.

04/22/2021

The knowledgeable and responsive support team offers valuable assistance and expertise, making troubleshooting and problem-solving much more efficient.

10/07/2017

Its purity and functionality have been extensively tested, ensuring reliable and reproducible results in my research.

Q&As

What are the current challenges in targeting ALDH1L1 protein for therapeutic purposes?

The precise role of ALDH1L1 protein in various diseases is still being elucidated, and developing effective therapies targeting this protein presents challenges.

What are the potential side effects of targeting ALDH1L1 protein for therapeutic purposes?

Targeting ALDH1L1 protein may have potential side effects related to its role in folate metabolism and neural stem cell maintenance.

How does the expression of ALDH1L1 protein vary in different cancer types?

The expression of ALDH1L1 protein can vary significantly across different cancer types, potentially making it a valuable target for personalized therapies.

Can ALDH1L1 protein be a potential therapeutic target for cancer treatment?

Research suggests that targeting ALDH1L1 protein could potentially be a strategy for cancer treatment, but further studies are needed to determine its efficacy.

How does the expression of ALDH1L1 protein change with age?

Research suggests that the expression of ALDH1L1 protein may decrease with age, which could have implications for age-related diseases.